UnratedDrug recall · FDA · Published September 9, 2019
West-Ward Oxcarbazepine Oral Suspension Recall: Impurities May Cause Harm
West-Ward recalls 250mL Oxcarbazepine Oral Suspension due to failed impurities/degradation specifications. Rx-only product with specific lots and expiry dates. Consumers should contact pharmacy for guidance.
“West-Ward Oxcarbazepine Oral Suspension Recall: Impurities May Cause Harm.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38018-west-ward-oxcarbazepine-oral-suspension-recall-impurities-may-cause-harm. Based on FDA recall #D-1863-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1863-2019%22&limit=1).
The FDA announced on Sept. 9, 2019, that West-Ward Columbus Inc voluntarily recalled Oxcarbazepine Oral Suspension due to failed impurity specifications. The recall affects 32,347 bottles distributed nationwide and in Puerto Rico.
How to tell if you have it
Brand: West-Ward
Product: Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle
NDC: 0054-0199-59
Lot codes: AA3957A (exp May 2020), AA3958A (exp May 2020), AA5164A (exp Sep 2020)
Quantity: 32,347 bottles
Distribution: Nationwide USA and Puerto Rico
The hazard
The recall was issued because the Oxcarbazepine Oral Suspension failed impurity specifications. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show West-Ward Columbus Inc has 8 other recalls on record since May 19, 2016. Other recent recalls of similar products include West-Ward Methadone Tablets Recall (Dec. 19, 2024), West-Ward Methotrexate Tablets Recall (Sept. 22, 2023), and West-Ward Recalls Leucovorin Calcium Tablets Due to Labeling Error (July 22, 2020). Other recent recalls of similar products include Novadoz Glycopyrrolate Oral Solution Recall (Dec. 15, 2025), Macleods Olanzapine Tablets 5mg Recall (Aug. 27, 2026), and Sagent Busulfan Injection Recall (May 4, 2026).
How to tell if you have this one
Check the product label for the lot numbers AA3957A, AA3958A, or AA5164A and expiry dates of May 2020 or September 2020. The product is a 250mL bottle of oxcarbazepine oral suspension, prescription-only.
Brand
West-Ward
Category
Drug
Based on the official FDA remedy
What to do — step by step
Contact Pharmacy
Talk to your pharmacy about the recalled product and get guidance on next steps.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.8 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1863-2019 (September 9, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1863-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.